Literature DB >> 1557244

Cerebroelectrical depression following surfactant treatment in preterm neonates.

L Hellström-Westas1, A H Bell, L Skov, G Greisen, N W Svenningsen.   

Abstract

During surfactant treatment of respiratory distress syndrome, 23 premature newborns were investigated with continuous amplitude-integrated electroencephalography (cerebral function monitors). Simultaneously, arterial blood pressure and transcutaneous blood gas values were recorded. A short (less than 10 minutes) but significant decrease in cerebral activity was seen in almost all neonates immediately after the surfactant instillation, in spite of an improved pulmonary function. In 21 of 23 neonates, a transient fall in mean arterial blood pressure of 9.3 mm Hg (mean) occurred coincidently with the cerebral reaction. Neonates in whom intraventricular hemorrhage developed tended to have lower presurfactant mean arterial blood pressure (P greater than .05), but they had a significantly lower mean arterial blood pressure after surfactant instillation (P less than .05). No other differences were found between neonates in whom intraventricular hemorrhage developed and those without intraventricular hemorrhage. The present findings demonstrate that an acute cerebral dysfunction may occur after surfactant instillation. In some vulnerable neonates with arterial hypotension and severe pulmonary immaturity, the fall in mean arterial blood pressure may increase the risk of cerebral complications and could be related to an unchanged rate of intraventricular hemorrhage after surfactant treatment.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1557244

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  12 in total

Review 1.  Current perspectives on the drug treatment of neonatal respiratory distress syndrome.

Authors:  D G Sweet; H L Halliday
Journal:  Paediatr Drugs       Date:  1999 Jan-Mar       Impact factor: 3.022

Review 2.  Role of cerebral function monitoring in the newborn.

Authors:  L S de Vries; L Hellström-Westas
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-05       Impact factor: 5.747

3.  A risk-benefit assessment of natural and synthetic exogenous surfactants in the management of neonatal respiratory distress syndrome.

Authors:  H Walti; M Monset-Couchard
Journal:  Drug Saf       Date:  1998-05       Impact factor: 5.606

Review 4.  Surfactant replacement therapy.

Authors:  M J Kresch; W H Lin; R S Thrall
Journal:  Thorax       Date:  1996-11       Impact factor: 9.139

5.  Low-voltage aEEG as predictor of intracranial hemorrhage in preterm infants.

Authors:  Lina F Chalak; Natalie C Sikes; Melanie J Mason; Jeffrey R Kaiser
Journal:  Pediatr Neurol       Date:  2011-05       Impact factor: 3.372

6.  Instillation rate effects of Exosurf on cerebral and cardiovascular haemodynamics in preterm neonates.

Authors:  E Saliba; M Nashashibi; M C Vaillant; C Nasr; J Laugier
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-11       Impact factor: 5.747

Review 7.  Clinical pharmacology of analgosedatives in neonates: ways to improve their safe and effective use.

Authors:  Anne Smits; John N van den Anker; Karel Allegaert
Journal:  J Pharm Pharmacol       Date:  2016-06-30       Impact factor: 3.765

8.  Modified bovine surfactant (Survanta) versus a protein-free surfactant (Exosurf) in the treatment of respiratory distress syndrome in preterm infants: a pilot study.

Authors:  S S Sehgal; C K Ewing; T Richards; H W Taeusch
Journal:  J Natl Med Assoc       Date:  1994-01       Impact factor: 1.798

9.  Hemodynamics of respiratory failure in rabbit model: effect of surfactant supplementation.

Authors:  M Barsotti; V Chundu; S Silvka; J Sephus; M Hallman
Journal:  Lung       Date:  1996       Impact factor: 2.584

10.  Randomised clinical trial of two treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome.

Authors:  C P Speer; O Gefeller; P Groneck; E Laufkötter; C Roll; L Hanssler; K Harms; E Herting; H Boenisch; J Windeler
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-01       Impact factor: 5.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.